BRK-B vs GF
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
GF presents as a classic deep-value play, characterized by a stable Piotroski F-Score of 4/9 and a massive valuation discount. The stock is trading significantly below both its Graham Number ($31.31) and Intrinsic Value ($24.01), with a remarkably low P/E of 3.37 and a Price/Book ratio of 0.91. While technical trends are currently bearish and liquidity ratios (Quick Ratio 0.04) are concerning, the strong ROE of 31.04% and low debt-to-equity ratio provide a solid fundamental floor.
Compare Another Pair
Related Comparisons
BRK-B vs GF: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and The New Germany Fund, Inc. (GF) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.